DE2318021A1 - Neue krebsmittel - Google Patents
Neue krebsmittelInfo
- Publication number
- DE2318021A1 DE2318021A1 DE2318021A DE2318021A DE2318021A1 DE 2318021 A1 DE2318021 A1 DE 2318021A1 DE 2318021 A DE2318021 A DE 2318021A DE 2318021 A DE2318021 A DE 2318021A DE 2318021 A1 DE2318021 A1 DE 2318021A1
- Authority
- DE
- Germany
- Prior art keywords
- platinum
- complexes according
- groups
- platinum complexes
- phenylenediamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims description 18
- 201000011510 cancer Diseases 0.000 title claims description 8
- 150000003057 platinum Chemical class 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 7
- -1 amino, hydroxy Chemical group 0.000 claims description 6
- 125000002577 pseudohalo group Chemical group 0.000 claims description 6
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical group OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 4
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 3
- 238000007912 intraperitoneal administration Methods 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims description 2
- 150000001540 azides Chemical class 0.000 claims description 2
- RIIWUGSYXOBDMC-UHFFFAOYSA-N benzene-1,2-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=CC=C1N RIIWUGSYXOBDMC-UHFFFAOYSA-N 0.000 claims description 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 125000000271 carboxylic acid salt group Chemical group 0.000 claims 1
- 239000012059 conventional drug carrier Substances 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 230000036210 malignancy Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 4
- 208000033014 Plasma cell tumor Diseases 0.000 description 4
- 208000007452 Plasmacytoma Diseases 0.000 description 4
- 208000010626 plasma cell neoplasm Diseases 0.000 description 4
- 231100001274 therapeutic index Toxicity 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- QLXHAGHQLRUWLX-UHFFFAOYSA-N 1-n,2-n-dichlorobenzene-1,2-diamine Chemical compound ClNC1=CC=CC=C1NCl QLXHAGHQLRUWLX-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000003058 platinum compounds Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- DOIGLVPYOVTOIY-UHFFFAOYSA-L (2-azanidyl-4,5-dimethylphenyl)azanide;dichloroplatinum(2+) Chemical compound Cl[Pt+2]Cl.CC1=CC([NH-])=C([NH-])C=C1C DOIGLVPYOVTOIY-UHFFFAOYSA-L 0.000 description 1
- BPDQNDNSWGOEJU-UHFFFAOYSA-L (2-azanidylphenyl)azanide;platinum(4+);dichloride Chemical compound Cl[Pt+2]Cl.[NH-]C1=CC=CC=C1[NH-] BPDQNDNSWGOEJU-UHFFFAOYSA-L 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- XSZYBMMYQCYIPC-UHFFFAOYSA-N 4,5-dimethyl-1,2-phenylenediamine Chemical class CC1=CC(N)=C(N)C=C1C XSZYBMMYQCYIPC-UHFFFAOYSA-N 0.000 description 1
- 235000018259 Solanum vestissimum Nutrition 0.000 description 1
- 240000002825 Solanum vestissimum Species 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- BSJGASKRWFKGMV-UHFFFAOYSA-L ammonia dichloroplatinum(2+) Chemical compound N.N.Cl[Pt+2]Cl BSJGASKRWFKGMV-UHFFFAOYSA-L 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001734 carboxylic acid salts Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1645172A GB1432563A (en) | 1972-04-10 | 1972-04-10 | Platinum- co-ordination compounds |
| GB2139072 | 1972-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2318021A1 true DE2318021A1 (de) | 1973-11-08 |
Family
ID=26252050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2318021A Pending DE2318021A1 (de) | 1972-04-10 | 1973-04-10 | Neue krebsmittel |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3904663A (https=) |
| JP (1) | JPS535369B2 (https=) |
| DE (1) | DE2318021A1 (https=) |
| FR (1) | FR2182942B1 (https=) |
| GB (1) | GB1432563A (https=) |
| NL (1) | NL7304881A (https=) |
| SE (1) | SE396755B (https=) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4419340A (en) * | 1969-03-24 | 1983-12-06 | University Of Delaware | Controlled release of anticancer agents from biodegradable polymers |
| GB1578323A (en) * | 1976-02-26 | 1980-11-05 | Rustenburg Platinum Mines Ltd | Compositions containing platinum |
| GB1585103A (en) * | 1976-04-06 | 1981-02-25 | Rustenburg Platinum Mines Ltd | Pharmaceutical compositions containing platinum compounds |
| US4255417A (en) * | 1976-08-04 | 1981-03-10 | Johnson Matthey, Inc. | Platinum compounds for the irradication of skin blemishes |
| US4115418A (en) * | 1976-09-02 | 1978-09-19 | Government Of The United States Of America | 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity |
| JPS6041077B2 (ja) * | 1976-09-06 | 1985-09-13 | 喜徳 喜谷 | １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体 |
| US4278660A (en) * | 1977-05-02 | 1981-07-14 | Research Corporation | Complex or salt of a platinum (II) compound and a nitrogen containing polymer |
| US4151185A (en) * | 1977-05-02 | 1979-04-24 | Research Corporation | Complex or salt of a platinum (II) compound and a nitrogen containing polymer |
| US4137248A (en) * | 1977-08-29 | 1979-01-30 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof |
| JPS5829957B2 (ja) * | 1977-09-12 | 1983-06-25 | 喜徳 喜谷 | 新規な白金錯体 |
| SE447385B (sv) * | 1977-10-19 | 1986-11-10 | Johnson Matthey Co Ltd | Cis-koordinationsforeningar av platina |
| US4203912A (en) * | 1977-10-19 | 1980-05-20 | Johnson, Matthey & Co., Limited | Compositions containing platinum |
| SE447902B (sv) * | 1977-10-19 | 1986-12-22 | Johnson Matthey Co Ltd | Cis-koordinationsforening av platina och komposition innehallande foreningen |
| NL7807334A (nl) * | 1978-07-06 | 1980-01-08 | Tno | Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel. |
| US4405757A (en) * | 1979-09-14 | 1983-09-20 | Howell Bobby A | Macromolecular complexes of amidocarbonylic water-soluble polymers and square planar platinous and equivalent organometallics |
| US4578491A (en) * | 1982-06-28 | 1986-03-25 | Engelhard Corporation | Bis(thiocyanato)palladium(II) complexes |
| IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
| US4560782A (en) * | 1982-11-19 | 1985-12-24 | Research Corporation | Anti-tumor diplatinum coordination compounds |
| US4533502A (en) * | 1983-02-22 | 1985-08-06 | Rochon Fernande D | Platinum (II) compounds and their preparation |
| ATE52517T1 (de) * | 1983-05-10 | 1990-05-15 | Andrulis Res Corp | Bis-platinkomplexe als antitumor-mittel. |
| US4544759A (en) * | 1983-07-29 | 1985-10-01 | American Cyanamid Company | Platinum complexes of antitumor agents |
| US4588831A (en) * | 1984-11-09 | 1986-05-13 | Natec | Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use |
| US5041581A (en) * | 1985-10-18 | 1991-08-20 | The University Of Texas System Board Of Regents | Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| US5117022A (en) * | 1985-10-18 | 1992-05-26 | The Board Of Regents, The University Of Texas System | Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| US5384127A (en) * | 1985-10-18 | 1995-01-24 | Board Of Regents, The University Of Texas System | Stable liposomal formulations of lipophilic platinum compounds |
| US5393909A (en) * | 1988-11-22 | 1995-02-28 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
| US5041578A (en) * | 1988-11-22 | 1991-08-20 | Board Of Regents, The University Of Texas System | Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents |
| US5434256A (en) * | 1988-11-22 | 1995-07-18 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
| US5843475A (en) | 1996-12-06 | 1998-12-01 | Board Of Regents, The University Of Texas System | Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes |
| US6588615B1 (en) * | 1999-09-14 | 2003-07-08 | Smithkline Beecham Corporation | Container closure system having a cap removable with less than a 45° twist |
| AU1608801A (en) | 1999-11-15 | 2001-05-30 | Parker Hughes Institute | Diamino platinum (ii) antitumor complexes |
| CA2535584A1 (en) * | 2003-08-13 | 2005-02-24 | University Of South Florida | Platinum complexes for the treatment of tumors |
| US20050288365A1 (en) * | 2004-01-06 | 2005-12-29 | Heidi Kay | Platinum complexes and methods for inhibiting tumor cell proliferation |
| US7977500B2 (en) * | 2004-11-10 | 2011-07-12 | University Of South Florida | Platinum complexes for targeted drug delivery |
| WO2007006019A1 (en) * | 2005-07-06 | 2007-01-11 | University Of South Florida | Materials and methods for screening, diagnosis and prognosis of conditions associated with stat protein expression |
| EP2345974B1 (en) | 2006-06-28 | 2014-08-06 | IHI Corporation | Magnetically guidable compound |
| JP4774536B2 (ja) * | 2006-11-06 | 2011-09-14 | 株式会社Ｉｈｉ | 磁性材料、磁性材料の誘導装置及び磁性材料の設計方法 |
| US20090169484A1 (en) | 2007-12-28 | 2009-07-02 | Ihi Corporation | Iron-salen complex |
| JP5513405B2 (ja) | 2008-11-20 | 2014-06-04 | 株式会社Ｉｈｉ | 自己磁性金属サレン錯体化合物 |
| DK3327148T3 (da) | 2010-06-18 | 2021-04-12 | Myriad Genetics Inc | Fremgangsmåder til forudsigelse af status for brca1- og brca2-gener i en cancercelle |
| ES2704303T3 (es) | 2010-08-24 | 2019-03-15 | Dana Farber Cancer Inst Inc | Procedimientos para la predicción de una respuesta contra el cáncer |
| EP4563709A3 (en) | 2011-06-17 | 2025-09-03 | Myriad Genetics, Inc. | Methods and materials for assessing allelic imbalance |
| CN107267598B (zh) | 2011-12-21 | 2022-03-25 | 美瑞德生物工程公司 | 用于评估杂合性丢失的方法与材料 |
| WO2013130347A1 (en) | 2012-02-23 | 2013-09-06 | The Children's Hospital Corporation | Methods for predicting anti-cancer response |
| ES2658867T3 (es) | 2012-06-07 | 2018-03-12 | Institut Curie | Métodos para detectar la inactivación de la ruta de recombinación homóloga (BRCA1/2) en tumores humanos |
| WO2014160080A1 (en) | 2013-03-14 | 2014-10-02 | Children's Medical Center Corporation | Cancer diagnosis, treatment selection and treatment |
| DK2981624T3 (da) | 2013-04-05 | 2020-03-02 | Myriad Genetics Inc | Fremgangsmåder til vurdering af homolog rekombinationsdeficiens og forudsigelse af respons på cancerbehandling |
| EP3080292B1 (en) | 2013-12-09 | 2022-02-02 | Institut Curie | Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors |
| EP4234711B1 (en) | 2014-08-15 | 2025-05-28 | Myriad Genetics, Inc. | Methods and materials for assessing homologous recombination deficiency |
| EP4141127B1 (en) | 2021-08-30 | 2024-10-09 | Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln | Method for assessing homologous recombination deficiency in ovarian cancer cells |
-
1972
- 1972-04-10 GB GB1645172A patent/GB1432563A/en not_active Expired
-
1973
- 1973-04-09 NL NL7304881A patent/NL7304881A/xx not_active Application Discontinuation
- 1973-04-09 FR FR7312663A patent/FR2182942B1/fr not_active Expired
- 1973-04-09 US US349187A patent/US3904663A/en not_active Expired - Lifetime
- 1973-04-10 JP JP4078073A patent/JPS535369B2/ja not_active Expired
- 1973-04-10 SE SE7305077A patent/SE396755B/xx unknown
- 1973-04-10 DE DE2318021A patent/DE2318021A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US3904663A (en) | 1975-09-09 |
| SE396755B (sv) | 1977-10-03 |
| JPS535369B2 (https=) | 1978-02-27 |
| FR2182942B1 (https=) | 1976-10-22 |
| JPS4913317A (https=) | 1974-02-05 |
| NL7304881A (https=) | 1973-10-12 |
| GB1432563A (en) | 1976-04-22 |
| FR2182942A1 (https=) | 1973-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2318021A1 (de) | Neue krebsmittel | |
| DE3586759T2 (de) | Antitumor-platin-komplexe. | |
| EP0324154B1 (de) | 1,2-Bis(aminomethyl)cyclobutan-Platin-Komplexe | |
| DE2318019C2 (de) | Cis-Pt(II)-Koordinationsverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes pharmazeutisches Mittel | |
| DE69613254T2 (de) | Platinkomplexe | |
| DE2922523C2 (de) | Aminothiazole und diese enthaltende Arzneimitte l | |
| DE2341753C2 (de) | &alpha;-(3-tert.Butylamino-&alpha;-hydroxy-propylthio)- Thiazolderivate, Verfahren zu deren Herstellung und dieselben enthaltende pharmazeutische Zubereitung | |
| LU83982A1 (de) | Platin-diamin-komplexe,ein verfahren zu ihrer herstellung,ein verfahren zur herstellung eines arzneimittels unter einsatz eines derartigen platin-diamin-komplexes fuer die behandlung von krebs sowie das dabei erhaltene arzneimittel | |
| DD144780A5 (de) | Verfahren zur herstellung von platin-diaminkomplexen | |
| DE2329485A1 (de) | Platinkoordinationsverbindungen | |
| DE3031732A1 (de) | Stoffzusammensetzung insbesondere zur bekaempfung boesartiger geschwuelste | |
| DE3887194T2 (de) | Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung. | |
| DE69507694T2 (de) | Trinukleare kationische platinkomplexe mit antitumor wirkung sowie diese enthaltende pharmazeutische zusammensetzungen | |
| AT390610B (de) | Verfahren zur herstellung von neuen platin-(ii) -diaminkomplexen | |
| DE69126009T2 (de) | Zyklische (Hetero)Acetale nitrosubstituierter Benzaldehyde mit Wirkung gegen Krebs | |
| DE69105859T2 (de) | Thioharnstoffderivate und sie enthaltendes antimikrobielles Mittel und sie enthaltendes Mittel gegen Magengeschwüre. | |
| DE2318020A1 (de) | Krebsmittel | |
| DE68929050T2 (de) | 1,2,4-benzotriazinoxide als funkempfindliche und selektive zytotoxische mittel | |
| DE2830007B2 (de) | Inosadiaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antitumormittel | |
| EP0116955B1 (de) | (1,2-Diphenyl-ethylendiamin)-platin(II)-Komplexverbindungen | |
| DE69005676T2 (de) | Platinkomplexe und Antitumormittel, die diese als Wirkstoffe enthalten. | |
| WO2004099224A1 (de) | Carboplatin-artige platin (ii)- komplexe | |
| DE3788693T2 (de) | 3,5-Dichloro-2,4-dimethoxy-6-(trichlormethyl)pyridine. | |
| DE1670657C3 (de) | 4- eckige Klammer auf 5-NHrofurfuryliden-(2')-lmino eckige Klammer zu -tetrahydro-M-thlazln-i.i-dioxld-Derhrate und Verfahren zu Ihrer Herstellung | |
| DE68928802T2 (de) | 1,2,4-benzotriazin-n-oxidderivate als radiosensibilisierende und selektive cytotoxische mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHA | Expiration of time for request for examination |